Cargando…
Subconjunctival sustained-release dexamethasone implant as an adjunct to trabeculectomy for primary open angle glaucoma
Autores principales: | Furino, Claudio, Boscia, Francesco, Cicinelli, Maria Vittoria, Sborgia, Alessandra, Alessio, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869472/ https://www.ncbi.nlm.nih.gov/pubmed/27146944 http://dx.doi.org/10.4103/0301-4738.181735 |
Ejemplares similares
-
Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series
por: Choi, Jin Young, et al.
Publicado: (2010) -
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
por: Sedghipour, Mohammad-Reza, et al.
Publicado: (2011) -
Analysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant
por: Niro, Alfredo, et al.
Publicado: (2018) -
Surgical Management of Complications after Dexamethasone Implant
por: Sborgia, Giancarlo, et al.
Publicado: (2020) -
Augmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trial
por: Mostafaei, Ali
Publicado: (2011)